CORK, IRELAND--(Marketwire - June 02, 2010) -
QUMAS, the leading provider of Compliance Solutions to highly regulated companies, today announced that EirGen Pharma has selected DocCompliance and ProcessCompliance. The two products will provide EirGen with a flexible solution that will be used to manage both documents and business processes.
QUMAS DocCompliance and ProcessCompliance will provide EirGen Pharma with an integrated solution to improve document control and reduce approval lifecycles of regulatory documents. EirGen Pharma will also use the integrated solution to automate Change Control and Non-Conformance Management to drive efficiencies across both processes. EirGen Pharma will roll out the QUMAS solution to all employees.
"Our solution will provide EirGen with a single platform to manage all of their compliance programs," stated Kevin O'Leary, CEO. "This will enable EirGen to dramatically reduce their compliance costs and create a competitive advantage."
"EirGen as a business is scaling rapidly and needs the infrastructure to support this growth. From a documentation control and compliance perspective, QUMAS provides the solution to this challenge," said Patsy Carney, Managing Director at EirGen Pharma. "QUMAS has provided us with a cost effective and flexible solution that addresses our compliance issues today, and can be expanded to meet our future needs."
QUMAS is the leader in Enterprise Compliance Solutions with more than 250 global customer deployments and over 15 years of experience helping companies in highly regulated industries. For more information visit www.qumas.com.
About EirGen Pharma
EirGen Pharma is a pharmaceutical company based in Waterford, Ireland. Using its purpose built high containment facility; the company specializes in the development, registration and manufacture of high potency solid dose products for global markets.
For more information visit http://www.eirgen.com.
All trade names, trademarks, and service marks are rightful property of their respective owners.